ATI PN Pharmacology Level 3 Proctored Exam Prep
Document 2026/2027 | Practical Nursing Pharmacology,
Medication Safety & NGN-PN Clinical Judgment | 60
Verified Questions with Detailed Rationales
Abstract
This examination contains verified questions drawn from actual ATI PN Pharmacology Level 3 Proctored
Exam for the 2026/2027 academic year. It covers pharmacokinetics and pharmacodynamics, safe
medication administration, cardiovascular, endocrine, anti-infective, neurologic, psychiatric, and pain
management pharmacology, medication safety principles, and NGN-PN clinical judgment application.
Questions are aligned with the ATI PN Pharmacology Level 3 competencies and designed to help
practical nursing students achieve Level 2 or higher on the ATI Pharmacology Proctored Exam.
Content Area Overview
Pharmacokinetics, Pharmacodynamics & Medication Principles – Covers absorption, distribution,
metabolism, and excretion; drug interactions; protein binding; therapeutic index and narrow
therapeutic index drugs; half-life; first-pass effect; onset, peak, and duration.
Safe Medication Administration & Error Prevention – Addresses high-alert medications, medication
reconciliation, the "Five Rights," barcode scanning, independent verification, allergy review, controlled
substance wasting, patient refusal management, and safe abbreviation practices.
Cardiovascular, Endocrine & Anti-infective Pharmacology – Examines ACE inhibitors, beta-blockers,
diuretics, digoxin, warfarin, statins; insulin, metformin, levothyroxine, corticosteroids; antibiotics,
antivirals, antifungals; adverse effects, monitoring parameters, and key nursing interventions.
Neurologic, Psychiatric & Pain Management Medications – Focuses on benzodiazepines,
antidepressants, antipsychotics, anticonvulsants, sedative-hypnotics; opioids, NSAIDs, reversal agents;
substance intoxication and withdrawal; controlled substance monitoring; and patient education.
NGN-PN Clinical Judgment, Adverse Effects & Patient Education – Applies the NGN-PN clinical judgment
framework to pharmacotherapy (recognize cues, analyze, prioritize, generate solutions, take action,
evaluate outcomes) with emphasis on identifying adverse effects, reporting significant findings, and
providing patient-centered education.
,Section 1: Pharmacokinetics, Pharmacodynamics & Medication Principles – Questions 1–10
Q1: A practical nurse is reviewing a medication order for a client who has severe liver disease. The nurse
understands that this client's ability to metabolize most medications will be significantly impaired.
Which pharmacokinetic process is primarily affected?
A. Absorption
B. Distribution
C. Metabolism [CORRECT]
D. Excretion
Correct Answer: C
Rationale: The best answer is metabolism because the liver is the primary site of drug metabolism
through enzymatic processes like the cytochrome P450 system. When liver function is compromised,
drugs metabolized by the liver accumulate in the body, potentially causing toxicity even at normal
doses. Absorption occurs mainly in the GI tract, distribution depends on blood flow and protein binding,
and excretion is primarily a kidney function.
Q2: A client is prescribed a medication with a narrow therapeutic index. The practical nurse understands
that this means:
A. The drug is very safe and can be given in a wide range of doses
B. There is a small margin between the effective dose and the toxic dose, requiring close monitoring
[CORRECT]
C. The drug is ineffective at low doses
D. The drug has no adverse effects
Correct Answer: B
Rationale: This choice is correct because narrow therapeutic index (NTI) drugs like digoxin, warfarin, and
lithium have a small window between therapeutic benefit and harmful toxicity. Small changes in dose,
metabolism, or drug interactions can push levels into the danger zone. These drugs require frequent
blood level monitoring and careful dose adjustments. Wide safety margins, ineffectiveness at low doses,
and absence of adverse effects are all opposite of what NTI means.
Q3: A client takes an oral medication that undergoes significant metabolism in the liver before reaching
systemic circulation. This phenomenon is known as:
A. Bioavailability
B. First-pass effect [CORRECT]
, C. Protein binding
D. Half-life
Correct Answer: B
Rationale: This aligns with pharmacokinetic principles—the first-pass effect describes how orally
administered drugs are absorbed through the GI tract, transported via the portal vein to the liver, and
partially metabolized before they ever reach the general circulation. This reduces bioavailability for
many drugs, which is why some medications are given by other routes (sublingual, transdermal,
injection) to bypass the liver.
Q4: A practical nurse is administering a sublingual nitroglycerin tablet. The nurse understands that
sublingual administration bypasses which pharmacokinetic process that would occur with oral
administration?
A. Absorption
B. Distribution
C. The first-pass effect [CORRECT]
D. Excretion
Correct Answer: C
Rationale: This choice is correct because sublingual administration places the drug under the tongue
where it dissolves and is absorbed directly into the systemic circulation through the rich vascular
network, completely bypassing the GI tract and the portal vein route to the liver. This avoids first-pass
metabolism, allowing more rapid onset and higher bioavailability—critical for emergency medications
like nitroglycerin.
Q5: A client is receiving a highly protein-bound drug. The nurse understands that if the client's albumin
levels are low due to malnutrition, what is likely to happen to the free (unbound) drug concentration?
A. The free drug concentration will decrease
B. The free drug concentration will increase, potentially causing toxicity [CORRECT]
C. The total drug concentration will increase
D. Protein binding will have no effect on drug action
Correct Answer: B
Rationale: This matches pharmacodynamic principles—when albumin is low, less drug binds to protein,
leaving more free drug available to exert pharmacological effects. Free drug is the active form, so low
protein states can cause exaggerated responses or toxicity even with normal total drug levels. This is
particularly important with drugs like warfarin and phenytoin.
Document 2026/2027 | Practical Nursing Pharmacology,
Medication Safety & NGN-PN Clinical Judgment | 60
Verified Questions with Detailed Rationales
Abstract
This examination contains verified questions drawn from actual ATI PN Pharmacology Level 3 Proctored
Exam for the 2026/2027 academic year. It covers pharmacokinetics and pharmacodynamics, safe
medication administration, cardiovascular, endocrine, anti-infective, neurologic, psychiatric, and pain
management pharmacology, medication safety principles, and NGN-PN clinical judgment application.
Questions are aligned with the ATI PN Pharmacology Level 3 competencies and designed to help
practical nursing students achieve Level 2 or higher on the ATI Pharmacology Proctored Exam.
Content Area Overview
Pharmacokinetics, Pharmacodynamics & Medication Principles – Covers absorption, distribution,
metabolism, and excretion; drug interactions; protein binding; therapeutic index and narrow
therapeutic index drugs; half-life; first-pass effect; onset, peak, and duration.
Safe Medication Administration & Error Prevention – Addresses high-alert medications, medication
reconciliation, the "Five Rights," barcode scanning, independent verification, allergy review, controlled
substance wasting, patient refusal management, and safe abbreviation practices.
Cardiovascular, Endocrine & Anti-infective Pharmacology – Examines ACE inhibitors, beta-blockers,
diuretics, digoxin, warfarin, statins; insulin, metformin, levothyroxine, corticosteroids; antibiotics,
antivirals, antifungals; adverse effects, monitoring parameters, and key nursing interventions.
Neurologic, Psychiatric & Pain Management Medications – Focuses on benzodiazepines,
antidepressants, antipsychotics, anticonvulsants, sedative-hypnotics; opioids, NSAIDs, reversal agents;
substance intoxication and withdrawal; controlled substance monitoring; and patient education.
NGN-PN Clinical Judgment, Adverse Effects & Patient Education – Applies the NGN-PN clinical judgment
framework to pharmacotherapy (recognize cues, analyze, prioritize, generate solutions, take action,
evaluate outcomes) with emphasis on identifying adverse effects, reporting significant findings, and
providing patient-centered education.
,Section 1: Pharmacokinetics, Pharmacodynamics & Medication Principles – Questions 1–10
Q1: A practical nurse is reviewing a medication order for a client who has severe liver disease. The nurse
understands that this client's ability to metabolize most medications will be significantly impaired.
Which pharmacokinetic process is primarily affected?
A. Absorption
B. Distribution
C. Metabolism [CORRECT]
D. Excretion
Correct Answer: C
Rationale: The best answer is metabolism because the liver is the primary site of drug metabolism
through enzymatic processes like the cytochrome P450 system. When liver function is compromised,
drugs metabolized by the liver accumulate in the body, potentially causing toxicity even at normal
doses. Absorption occurs mainly in the GI tract, distribution depends on blood flow and protein binding,
and excretion is primarily a kidney function.
Q2: A client is prescribed a medication with a narrow therapeutic index. The practical nurse understands
that this means:
A. The drug is very safe and can be given in a wide range of doses
B. There is a small margin between the effective dose and the toxic dose, requiring close monitoring
[CORRECT]
C. The drug is ineffective at low doses
D. The drug has no adverse effects
Correct Answer: B
Rationale: This choice is correct because narrow therapeutic index (NTI) drugs like digoxin, warfarin, and
lithium have a small window between therapeutic benefit and harmful toxicity. Small changes in dose,
metabolism, or drug interactions can push levels into the danger zone. These drugs require frequent
blood level monitoring and careful dose adjustments. Wide safety margins, ineffectiveness at low doses,
and absence of adverse effects are all opposite of what NTI means.
Q3: A client takes an oral medication that undergoes significant metabolism in the liver before reaching
systemic circulation. This phenomenon is known as:
A. Bioavailability
B. First-pass effect [CORRECT]
, C. Protein binding
D. Half-life
Correct Answer: B
Rationale: This aligns with pharmacokinetic principles—the first-pass effect describes how orally
administered drugs are absorbed through the GI tract, transported via the portal vein to the liver, and
partially metabolized before they ever reach the general circulation. This reduces bioavailability for
many drugs, which is why some medications are given by other routes (sublingual, transdermal,
injection) to bypass the liver.
Q4: A practical nurse is administering a sublingual nitroglycerin tablet. The nurse understands that
sublingual administration bypasses which pharmacokinetic process that would occur with oral
administration?
A. Absorption
B. Distribution
C. The first-pass effect [CORRECT]
D. Excretion
Correct Answer: C
Rationale: This choice is correct because sublingual administration places the drug under the tongue
where it dissolves and is absorbed directly into the systemic circulation through the rich vascular
network, completely bypassing the GI tract and the portal vein route to the liver. This avoids first-pass
metabolism, allowing more rapid onset and higher bioavailability—critical for emergency medications
like nitroglycerin.
Q5: A client is receiving a highly protein-bound drug. The nurse understands that if the client's albumin
levels are low due to malnutrition, what is likely to happen to the free (unbound) drug concentration?
A. The free drug concentration will decrease
B. The free drug concentration will increase, potentially causing toxicity [CORRECT]
C. The total drug concentration will increase
D. Protein binding will have no effect on drug action
Correct Answer: B
Rationale: This matches pharmacodynamic principles—when albumin is low, less drug binds to protein,
leaving more free drug available to exert pharmacological effects. Free drug is the active form, so low
protein states can cause exaggerated responses or toxicity even with normal total drug levels. This is
particularly important with drugs like warfarin and phenytoin.
